News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mitchell Stephen Ray
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2023 |
4
| Mitchell Stephen Ray (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 6,500 shares
@ $6.0537, valued at
$39.3k
|
|
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/12/2023 |
4
| Mitchell Stephen Ray (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 17,307 shares
@ $0
Granted 33,960 options to buy
@ $6.5, valued at
$220.7k
|
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2021 |
4
| Mitchell Stephen Ray (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 19,109 shares
@ $16.7448, valued at
$320k
Exercised 5,985 options to buy
@ $10.57, valued at
$63.3k
Exercised 13,124 options to buy
@ $12.7, valued at
$166.7k
|
|
| 06/17/2021 |
4
| Mitchell Stephen Ray (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 5,000 shares
@ $19.4244, valued at
$97.1k
Exercised 4,015 options to buy
@ $10.57, valued at
$42.4k
|
|
| 06/14/2021 |
4
| Mitchell Stephen Ray (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 10,000 options to buy
@ $19.21, valued at
$192.1k
|
|
| 06/15/2020 |
4
| Mitchell Stephen Ray (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 10,000 options to buy
@ $10.57, valued at
$105.7k
|
|
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|